MedTrace Logo

Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)

NCT02268981 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2015-09-03

No results posted yet for this study

Summary

This study will investigate the effects of a reservoir nasal cannula (Oxymizer®) compared to a conventional nasal cannula (CNC) in patients with idiopathic pulmonary fibrosis.

Conditions

Interventions

DEVICE

Oxymizer® compared to CNC

Oxygen Saturation measurement for 12 h with CNC

DEVICE

Oxymizer® compared to CNC

Oxygen Saturation measurement for 12 h with Oxymizer®

DEVICE

Oxymizer® compared to CNC

Saturation measurement for 12 h with Oxymizer® by reduced flow rate (-1l/min)

Sponsors & Collaborators

  • Schön Klinik Berchtesgadener Land

    lead OTHER

Principal Investigators

  • Klaus Kenn, Dr. med · Schoen Klinik BGL

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02268981 on ClinicalTrials.gov